Yazar "Kilinç, Yasemin Baranoğlu" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    A childhood secondary headache case associated with Langerhans cell histiocytosis
    (2023) Kilinç, Yasemin Baranoğlu; Daniş, Ayşegül; Halicioglu, Siddika
    Neurological involvement is very rare in patients with a diagnosis of Langerhans Cell Histiocytosis (LCH). During the course of the disease, headache can also be seen in addition to systemic effects. A 6 years old girl was admitted to the hospital with only a headache without any systemic symptoms and was diagnosed with LCH. Magnetic resonance imaging showed a solid mass extending from the sphenoid bone corpus to the left great wing of the sphenoid, left orbital apex, left posterior ethmoid cells, left cavernous sinus, and dural space. The correct decision for neuroimaging in patients with headaches is very important in terms of mortality and morbidity. We wanted to share our patient’s case who was diagnosed with LCH by presenting only with headache without any other systemic finding, to remind that LCH may be a secondary cause of headache.
  • Küçük Resim Yok
    Öğe
    Effect of COVID-19 pandemic on children undergone percutaneous endoscopic gastrostomy due to neurologic diseases
    (2022) Bekdaş, Mervan; Daniş, Ayşegül; Kilinç, Yasemin Baranoğlu; Yoldaş, Meyri Arzu; Öztürk, Hülya
    Aim: To investigate the effects of SAR-CoV-2 infection on nutritional status in patients who underwent \rpercutaneous endoscopic gastrostomy (PEG) for neurological disorders.\rMethods: The clinical and laboratory follow-up data of the patients who underwent PEG in our clinic between \r2002 and 2018 were evaluated before and during the pandemic. The results were analyzed statistically.\rResults: Twenty patients were included. They were 70.9±64.4 months old at the time of PEG, 97.9±67.8 \rmonths before the pandemic, and 105.5±60.8 months during the pandemic (p=0.048). Weight for age at the \rtime of PEG increased from 10.7±4.6 kg to 15.6±7.2 kg before the pandemic. Hemoglobin was 12.3±1.4 g/dl \rat the time of PEG, 13.5±1.6 g/dl before the pandemic (p=0.045). Vitamin D was 24.1±8.9 ng/ml at the time \rof PEG and increased to 45.7±9.7 ng/ml during the pandemic (p=0.018). The annual number of visits before \rthe pandemic was 9.8±5.7 and decreased to 2±1.7 during the pandemic (p=0.003). Twelve (%60) of the patients \rdeveloped PEG complications, 6(30%) had their PEG replaced. Those who had developed PEG complications \rhad low levels of albumin (3.3±0.4 vs 4±0.4 g/dl, p=0.022) and vitamin B12 (578±199 vs 1299±533 pg/ml, \rp=0.007). \rConclusions: Even if PEG is applied late, it provides a partial improvement in patients, but the COVID-19 \rpandemic reversed these benefits and caused an increase in PEG complications. In order for the patient to get \rthe maximum benefit from PEG, close follow-up is essential.